Friday, October 28, 2016: 8:30 AM-10:00 AM
Tracks: Pediatric ID, Adult ID
Moderators: Liise-Anne Pirofski, MD, FIDSA, Albert Einstein College of Medicine and Montefiore Medical Center and Vincent B. Young, MD, PhD, FIDSA, University of Michigan
HSV-2 Candidate Vaccine Virus Deleted in Glycoprotein D (ΔgD-2) Elicits High-Titer IgG2 Antibodies with Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Activity, Protects Mice from Skin and Vaginal Challenge with Cinical Isolates of HSV-1 and HSV-2, and Prevents the Establishment of Latency
CME Credits: No CME credit is offered for this session.
See more of: Oral Abstract Session